# FDA 483 - AmbioPharm, Inc - February 09, 2023

Source: https://www.globalkeysolutions.net/records/483/ambiopharm-inc/f5b141ab-3baf-4e5b-9481-6e991f46418e

> FDA 483 for AmbioPharm, Inc on February 09, 2023. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: AmbioPharm, Inc
- Inspection Date: 2023-02-09
- Product Type: drugs
- Office Name: FDA District Office — Atlanta, Georgia

## Related Documents

- [EIR - Unknown Date](https://www.globalkeysolutions.net/records/eir/ambiopharm-inc/54685be9-74ea-4ece-8d45-fb0d1fe88bb6)
- [483 - 2023-02-09](https://www.globalkeysolutions.net/records/483/ambiopharm-inc/f83aa53d-7258-462d-a339-d2766bebda32)

## Related Officers

- [Lilia M Lugo](https://www.globalkeysolutions.net/people/lilia-m-lugo/bd409997-f589-4d2d-b7ba-4b52f222e43e)

Company: https://www.globalkeysolutions.net/companies/ambiopharm-inc/6a51f093-2f5b-433d-8e97-8e33820a50bf

Office: https://www.globalkeysolutions.net/offices/fda-district-office-atlanta-georgia/08e638cc-47bb-48fc-ae1a-41fba6be88d3